Relating to breast implants, the Food and Drug Administration, and public health.

Expresses the sense of the House of Representatives that the Food and Drug Administration should: (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases.